Warrants of cryopreservation in assisted reproductive technology amidst COVID-19 pandemic
1Physiology and Climatology Division, ICAR-Indian Veterinary Research Institute (Deemed University), Bareilly, Uttar Pradesh, India
2Department of Physiology, Kerala Veterinary and Animal Sciences University, Wayanad, Kerala, India
*Corresponding author: G. Taru Sharma, Physiology and Climatology Division, ICAR-Indian Veterinary Research Institute (Deemed University), Bareilly, Uttar Pradesh, India. firstname.lastname@example.org
© 2020 Published by Scientific Scholar on behalf of Journal of Reproductive Healthcare and Medicine
How to cite this article: Thirupathi Y, Mankuzhy P, Chandra V, Sharma GT. Warrants of cryopreservation in assisted reproductive technology amidst COVID-19 pandemic. J Reprod Healthc Med 2021;2(Suppl_1):S49-S54.
Cryopreservation plays a central role in assisted reproductive technology (ART) by allowing in vitro fertilization (IVF) cycle segmentation, banking of supernumerary gametes, embryos, and fertility preservation. The identification of viral receptors on gametes and embryos raises serious concerns for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients who are interested in preserving fertility. The complications caused by the SARS-CoV-2 on IVF and embryo safety are yet to be explored. Scanty information is available so far regarding the risk of cryopreservation of biological materials used in ART. Here, we highlight the risks of cryopreservation in ART and safety measures to follow amidst the COVID-19 pandemic.
Assisted reproductive technology
Severe acute respiratory syndrome coronavirus-2